Indoco Remedies Limited(IN:INDOCO)
₹219.95+0.60 (+0.27%)
IN:INDOCO
Indoco Remedies Limited Revenue
₹219.95
At close:+0.60 (+0.27%)
Want to see IN:INDOCO full AI Analyst Report?
Indoco Remedies Limited (INDOCO) Revenue
0 Followers
Indoco Remedies Limited Revenue
Indoco Remedies Limited had a revenue of 4.66B in the quarter ending Jun 30, 2026, with -1.97%. This bring the company's revenue in the last twelve months to 18.59B, Increased 2.04%. In the fiscal year ending Mar 31, 2026, Indoco Remedies Limited had annual revenue of 18.45B with 10.84% growth.
- Revenue (ttm)
- 18.59B
- Revenue Growth
- 10.75%
- P/S Ratio
- 1.10
- Revenue/Employee
- INR 3,075,533
- Employees
- 6,000
- Market Cap
- INR 20.25B
Revenue Chart
Indoco Remedies Limited Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 18.45B | 1.80B | 10.84% |
| Mar 31, 2025 | 16.65B | -1.23B | -6.89% |
| Mar 31, 2024 | 17.88B | 1.48B | 9.03% |
| Mar 31, 2023 | 16.40B | 1.36B | 9.06% |
| Mar 31, 2022 | 15.04B | 2.85B | 23.40% |
| Mar 31, 2021 | 12.19B | 1.39B | 12.84% |
| Mar 31, 2020 | 10.80B | 1.38B | 14.64% |
| Mar 31, 2019 | 9.42B | -755.90M | -7.43% |
| Mar 31, 2018 | 10.18B | -791.00M | -7.21% |
| Mar 31, 2017 | 10.97B | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company | Revenue |
|---|---|
| IN:INDOCO | 18.59B |
| IN:APLLTD | 77.84B |
| IN:HIKAL | 17.33B |
| IN:MOREPENLAB | 19.51B |
| IN:SOLARA | 15.35B |
| IN:UNICHEMLAB | 23.08B |